Landscape of HTLV-1 in vitro diagnostic tests
diagnostics of human T-lymphotropic virus 1 (HTLV-1) remains largely undocumented. This study aimed to map the current landscape of HTLV-1 diagnostics in 13 countries to support the development of World Health Organization guidelines and aid countries in building effective public health responses. Through a review of regulatory records and consultations with government officials, we identified 25 screening assays and three confirmatory tests. While most assays used serum or plasma, two enzyme immunoassays in Brazil were approved for antibody detection in dried blood spots. Only Japan had registered a rapid diagnostic test, which is based on immunochromatography. Screening assays generally had good performance, with both high sensitivity (range: 97.8%-100%) and specificity (range: 99.4%-100%). Assays using dried blood spots also had good performance with 96%-100% sensitivity and 98.7%-99.4% specificity. Three confirmatory, antibody-based tests were identified, but no molecular diagnostic tests were registered. The number of registered screening assays per country varied widely (range: 0-15), revealing a fragmentation and inconsistency in the global market. To foster an effective public health response, expanding access to and uptake of HTLV-1 testing services using accurate and quality-assured products is a priority.
Authors
- Cheryl Johnson (ORCID: https://orcid.org/0000-0001-5499-5523)
- Masumichi Saito (ORCID: https://orcid.org/0000-0001-7187-1186)
- Mirna Marcela Biglione
- Daniel Bradshaw (ORCID: https://orcid.org/0000-0001-7186-2482)
- Tomoo Sato (ORCID: https://orcid.org/0000-0001-8439-3128)
- Sahar Bajis (ORCID: https://orcid.org/0000-0003-2663-3845)
- Thato Chidarikire (ORCID: https://orcid.org/0000-0002-2785-7640)
- Nicolás Ducasa (ORCID: https://orcid.org/0000-0003-4455-8295)
- Leandro Soares Sereno (ORCID: https://orcid.org/0000-0002-6756-3030)
- Graham Philip Taylor (ORCID: https://orcid.org/0000-0002-3773-2390)
- Álisson Bigolin (ORCID: https://orcid.org/0000-0003-4794-8045)
- Madoka Kuramitsu (ORCID: https://orcid.org/0000-0002-3064-5219)
- Patricia Jannet Garcia (ORCID: https://orcid.org/0000-0003-3874-2256)
- Yoshihisa Yamano (ORCID: https://orcid.org/0000-0001-7527-0345)
- Carlota Baptista
- Aileen G. Rowan (ORCID: https://orcid.org/0000-0002-7897-1814)
- Carolina Rosadas (ORCID: https://orcid.org/0000-0002-3922-5667)
- Nick Vandegraaff
- Toshiki Watanabe
- Magdalena Barr DiChiara
- Philippa Hetzel (ORCID: https://orcid.org/0009-0004-0916-3700)
Institutions
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- St. Marianna University School of Medicine (JP)
- Universidad Peruana Cayetano Heredia (PE)
- Universidad de Buenos Aires (AR)
- National Institute of Infectious Diseases (JP)
- World Health Organization Regional Office for the Americas (US)
- World Health Organization (CH)
- Instituto de Investigaciones Biomédicas en Retrovirus y Sida (AR)
- Ministério da Saúde (BR)
- UK Health Security Agency (GB)
- Instituto de Medicina Tropical Alexander von Humboldt (PE)
- Japan Institute for Health Security (JP)
- Imperial College London (GB)
- St Vincents Institute of Medical Research (AU)
Publication Details
- Journal
- Journal of Clinical Microbiology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1128/jcm.00580-26
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Imperial College London
- Medical Research Council
- NIHR Imperial Biomedical Research Centre